提高TNBC免疫疗法的疗效:基于免疫微环境的分析和亚型
Yalan Yang1, Haifeng Li1,2, Wei Yang1,2
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Frontiers in immunology
|October 21, 2024
概括
三重阴性乳腺癌 (TNBC) 免疫疗法显示出希望,但面临挑战. 对TNBC亚型和生物标志物的进一步研究对于开发更有针对性,更有效的治疗方法至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种缺乏向治疗的侵袭性亚型.
- 免疫疗法提供了希望,但由于瘤异质性和耐药性而面临局限性.
- 目前的PD-L1生物标志物在预测治疗反应方面的有效性有限.
研究的目的:
- 审查TNBC的瘤微环境和治疗干预措施.
- 总结目前用于免疫治疗的TNBC亚型和生物标志物策略.
- 强调需要新型生物标志物来完善针对TNBC亚型的向疗法.
主要方法:
- 关于TNBC瘤微环境的文献综述.
- 对当前免疫疗法策略和生物标志物的分析.
- 对TNBC的分类方法的综合.
主要成果:
- TNBC表现出多样化的微环境,有助于治疗耐药性.
- 尽管目前的免疫疗法取得了进展,但观察到患者受益有限.
- 像PD-L1这样的现有生物标志物具有低于最佳的预测值.
结论:
- 加强对TNBC亚型和微环境的理解至关重要.
- 开发新的生物标志物对于个性化免疫疗法至关重要.
- 需要量身定制的治疗策略来改善高级TNBC的结果.
相关概念视频
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K